Related Topics News -

     
 Title only   |   Print    Next page > 
     
和鉑醫藥合作夥伴Solstice完成逾2億美元A輪融資

2026-09-10T  
和鉑醫藥及科倫博泰:HBM9378/WIN378治療哮喘啟動III期研究

2026-09-09T  
《業績》和鉑醫藥中期純利6,488萬美元 倒退9.5%

2026-08-28T  
和鉑醫藥HBM7004治療晚期實體瘤新藥臨床獲批

2026-08-18T  
和鉑醫藥與國藥戰略合作 覆蓋腫瘤及免疫炎症等疾病領域

2026-07-27T  
《盈喜》和鉑醫藥料中期最多賺6,700萬美元

2026-07-24T  
和鉑醫藥HBM7575治療哮喘新藥臨床獲批

2026-07-15T  
百奧賽圖:和鉑醫藥發明專利訴訟請求一審被駁回

2026-06-30T  
和鉑醫藥升逾5% 美國專利侵權訴訟

2026-06-15T  
和鉑醫藥美國專利訴訟勝訴 法院裁定安進賠逾2,020萬美元

2026-06-15T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.